| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/13/2003 | US6562319 4-(phenylamino)quinazolines |
| 05/13/2003 | CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators |
| 05/08/2003 | WO2003037891A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| 05/08/2003 | WO2003037888A1 3-substituted-4-pyrimidone derivatives |
| 05/08/2003 | WO2003037878A1 Substituted pyrimidines |
| 05/08/2003 | WO2003037877A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3β INHIBITORS |
| 05/08/2003 | WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 05/08/2003 | US20030088096 Preparation by cleavage of triazolopyrimidines or by cyanoamination of sulfonylpyrimidines |
| 05/08/2003 | US20030087923 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 05/08/2003 | US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines |
| 05/08/2003 | US20030087921 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa. |
| 05/08/2003 | US20030087920 Butyne diol derivatives |
| 05/08/2003 | US20030087915 Pharmaceutical compositions and methods for use |
| 05/08/2003 | US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol |
| 05/08/2003 | US20030087306 Methods for identifying novel multimeric agents that modulate receptors |
| 05/08/2003 | US20030087151 Low melting point |
| 05/08/2003 | CA2463823A1 Aminobenzamide derivatives as glycogen synthase kinase 3.beta. inhibitors |
| 05/08/2003 | CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| 05/08/2003 | CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 05/07/2003 | EP1214316B1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 05/07/2003 | EP1085807B1 Use of 2-(n-phenylamino)pyrimidines as fungicides, and novel 2-(n-phenylamino)pyrimidines |
| 05/07/2003 | EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 05/07/2003 | EP0889863B1 Surface modified carbonate materials |
| 05/07/2003 | EP0719272B1 Pyrimidine derivatives for labeled binding partners |
| 05/07/2003 | CN1416423A 2,4,Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 05/07/2003 | CN1416422A Substituted benzoylcyclohexenones |
| 05/07/2003 | CN1416420A 1,2,3,4-tetrahydroisoquinoline derivatives |
| 05/07/2003 | CN1415606A Method of preparing compound of 0-substituted sulphonyl propylhomoserin class |
| 05/07/2003 | CN1107503C Optically pure compoun as medicinal use |
| 05/06/2003 | US6559307 Process for the preparation of substituted pyrimidines |
| 05/06/2003 | US6559160 These compounds and compositions bind to the CXCR3 chemokine receptor and are useful for treating diseases and conditions responsive to the modulation of CXCR3 activity, such as multiple sclerosis, rheumatoid arthritis, psoriasis, cancer, |
| 05/06/2003 | US6559155 Pyrimidinone derivatives for the treatment of atherosclerosis |
| 05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 05/02/2003 | EP1305296A2 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
| 05/02/2003 | EP1305288A1 Potassium channel inhibitors |
| 05/02/2003 | EP1305281A1 Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for the production thereof |
| 05/02/2003 | EP1305028A2 Antimicrobial biaryl compounds |
| 05/02/2003 | EP1305026A2 Barbituric acid analogs as therapeutic agents |
| 05/02/2003 | EP1028950B1 7-substituted quinazolin-2,4-diones useful as antibacterial agents |
| 05/02/2003 | EP0772593B1 Thiopyridyl compounds for controlling helicobacter bacteria |
| 05/01/2003 | WO2003035640A1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 05/01/2003 | WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 05/01/2003 | WO2003035609A1 Zwitterionic imides |
| 05/01/2003 | WO2003035602A1 Lipid modulators |
| 05/01/2003 | WO2003035077A1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 05/01/2003 | WO2003035076A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 05/01/2003 | WO2003006443A3 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy |
| 05/01/2003 | WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE |
| 05/01/2003 | WO2002076438A3 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis |
| 05/01/2003 | WO2001096318A8 Cyclic urea compounds and preparation thereof |
| 05/01/2003 | US20030083359 Treating pain, urinary incontinence and bladder overactivity; P2X receptors are cation-permeable ion channels |
| 05/01/2003 | US20030083333 1,4-Disubstituted benzo-fused compounds |
| 05/01/2003 | US20030083332 N-heterocyclic derivatives as NOS inhibitors |
| 05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/01/2003 | US20030083317 HIV inhibiting pyrimidine derivatives |
| 05/01/2003 | US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity |
| 05/01/2003 | CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 05/01/2003 | CA2463290A1 Zwitterionic imides |
| 04/30/2003 | CN1414955A Nitro-sulfobenzamides compound |
| 04/30/2003 | CN1414954A Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof |
| 04/30/2003 | CN1413990A Epimino substituted benzene derivative |
| 04/30/2003 | CN1107057C 3-amino-1-cyanophenyl-uracils |
| 04/30/2003 | CN1107056C Process for preparation of clonidine derivatives |
| 04/30/2003 | CN1107049C Benzyloxy substituted aromatics and their use as fungicides and insecticides |
| 04/29/2003 | US6555714 P-hydrophenylpyruvate dioxygenases (HPPD) from plants is incubated with test substrate and enzymatic activity of enzyme is determined in comparison with activity of uninhibited enzyme |
| 04/29/2003 | US6555687 Chloropyrimidine intermediates |
| 04/29/2003 | US6555686 Contacting qinazolinone with cyclopropylacetylene |
| 04/29/2003 | US6555684 Pyrimidinyl compounds for treatment of central nervous system disorders |
| 04/29/2003 | US6555572 Benzylated PDE4 inhibitors |
| 04/29/2003 | US6555566 Methods and materials for treating and preventing inflammation of mucosal tissue |
| 04/29/2003 | US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 04/29/2003 | US6554966 Process for preparing essentially formic acid-free N-alkyl-N′-methylalkyleneureas |
| 04/24/2003 | WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | WO2003033478A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | WO2003033477A1 Alkynlated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitor |
| 04/24/2003 | WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | WO2003033475A1 Process for the preparation of 1-(pyrimidin-2-yl)propan-2-ones |
| 04/24/2003 | WO2003033474A1 Process for the preparation of (pyrimmidin-2-yl)methyl ketones |
| 04/24/2003 | WO2003033472A1 Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors |
| 04/24/2003 | WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 04/24/2003 | WO2003032994A2 Novel tri-substituted pyrimidines, method for production and use thereof as medicament |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | WO2002022553A3 Non-natural basic amino acids, their preparation and use |
| 04/24/2003 | US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078271 Pyrimidine and indolone derivatives |
| 04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030077405 Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices |
| 04/24/2003 | CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | CA2463159A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/23/2003 | EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors |
| 04/23/2003 | EP1303496A1 Pyrimidine derivatives |